CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 158 enrolled
Drug / intervention
Use of EverLift +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04551014
NCT04551014N/ACompleted
CompareCT.gov

Randomized Controlled Trial Investigating Use of Submucosal Injection of EverLift in Rates of Complete Resection of Nonpedunculated Polyps 4-9mm

Stanford University·interventional·Posted Sep 16, 2020·Updated Sep 1, 2022

In Brief

A clinical study evaluating Use of EverLift and Without use of EverLift for Colo-rectal Cancer and 2 related conditions. Completed, enrolled 158 participants across 1 site.

Detailed Summary

The focus of the study is to evaluate impact of submucosal injection of EverLift in achieving complete resection during polypectomy of polyps 4-9mm during colonoscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColo-rectal Cancer, Polyp of Colon, Adenomatous Polyp of Colon
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 16, 2020
Enrollment StartSep 16, 2020
Primary CompletionMay 31, 2021
Study CompletionJul 15, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.8 years ago

Interventions

Use of EverLiftdevice

Use of EverLift for submucosal injection prior to polypectomy

Without use of EverLiftdevice

Without use of EverLift for submucosal injection prior to polypectomy